Alteration of the Function of the UDP-Glucuronosyltransferase 1A Subfamily by Cytochrome P450 3A4: Different Susceptibility for UGT Isoforms and UGT1A1/7 Variants

被引:30
|
作者
Ishii, Yuji [1 ]
Koba, Hiroki [1 ]
Kinoshita, Kousuke [1 ]
Oizaki, Toshiya [1 ]
Iwamoto, Yuki [1 ]
Takeda, Shuso [1 ]
Miyauchi, Yuu [1 ]
Nishimura, Yoshio [1 ]
Egoshi, Natsuki [1 ]
Taura, Futoshi [2 ]
Morimoto, Satoshi [2 ]
Ikushiro, Shin'ichi [3 ]
Nagata, Kiyoshi [4 ]
Yamazoe, Yasushi [5 ]
Mackenzie, Peter I. [6 ,7 ]
Yamada, Hideyuki [1 ]
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Med Resource Regulat, Fukuoka 8128582, Japan
[3] Toyama Prefectural Univ, Fac Engn, Biotechnol Res Ctr, Imizu, Toyama, Japan
[4] Tohoku Pharmaceut Univ, Sendai, Miyagi, Japan
[5] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan
[6] Flinders Med Ctr, Dept Clin Pharmacol, Adelaide, SA, Australia
[7] Flinders Univ S Australia, Adelaide, SA 5001, Australia
关键词
DRUG-METABOLIZING-ENZYMES; 7-ETHYL-10-HYDROXYCAMPTOTHECIN SN-38; ENDOPLASMIC-RETICULUM; NOMENCLATURE UPDATE; COLORECTAL-CANCER; ACTIVE METABOLITE; GENE SUPERFAMILY; POLYMORPHISMS; GLUCURONIDATION; IRINOTECAN;
D O I
10.1124/dmd.113.054833
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Functional protein-protein interactions between UDP-glucuronosyltransferase (UGT)1A isoforms and cytochrome P450 (CYP)3A4 were studied. To this end, UGT1A-catalyzed glucuronidation was assayed in Sf-9 cells that simultaneously expressed UGT and CYP3A4. In the kinetics of UGT1A6-catalyzed glucuronidation of serotonin, both Michaelis constant (K-m) and maximal velocity (V-max) were increased by CYP3A4. When CYP3A4 was coexpressed with either UGT1A1 or 1A7, the V-max for the glucuronidation of the irinotecan metabolite (SN-38) was significantly increased. S-50 and K-m both which are the substrate concentration giving 0.5 V-max were little affected by simultaneous expression of CYP3A4. This study also examined the catalytic properties of the allelic variants of UGT1A1 and 1A7 and their effects on the interaction with CYP3A4. Although the UGT1A1-catalyzing activity of 4-methylumbelliferone glucuronidation was reduced in its variant, UGT1A1(star)6, the coexpression of CYP3A4 restored the impaired function to a level comparable with the wild type. Similarly, simultaneous expression of CYP3A4 increased the Vmax of UGT1A7(star)1 (wild type) and (star)2 (N129K and R131K), whereas the same was not observed in UGT1A7(star)3 (N129K, R131K, and W208R). In the kinetics involving different concentrations of UDPglucuronic acid (UDP-GlcUA), the Km for UDP-GlcUA was significantly higher for UGT1A7(star)2 and (star)3 than (star)1. The Km of UGT1A7(star)1 and (star)3 was increased by CYP3A4, whereas (star)2 did not exhibit any such change. These results suggest that (1) CYP3A4 changes the catalytic function of the UGT1A subfamily in a UGT isoformspecific manner and (2) nonsynonymous mutations in UGT1A7(star)3 reduce not only the ability of UGT to use UDP-GlcUA but also CYP3A4-mediated enhancement of catalytic activity, whereas CYP3A4 is able to restore the UGT1A1(star)6 function.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 50 条
  • [31] Alteration of a PKC site of human UDP-glucuronosyltransferase (UGT)1A7 mimics the property of 1A10 due to a critical role of threonine and serine phosphorylation
    Basu, NK
    Owens, IS
    FASEB JOURNAL, 2004, 18 (08): : C72 - C72
  • [32] Genetic variants influence the XRE- and AHR-mediated transcriptional regulation and function of the human hepatic UDP-glucuronosyltransferase (UGT) 1A4 gene
    Erichsen, Thomas J.
    Ehmer, Ursula
    Lankisch, Tim O.
    Manns, Michael P.
    Strassburg, Christian P.
    HEPATOLOGY, 2006, 44 (04) : 519A - 520A
  • [33] Glycyrrhetinic Acid Exhibits Strong Inhibitory Effects Towards UDP-Glucuronosyltransferase (UGT) 1A3 and 2B7
    Huang, Yin-Peng
    Cao, Yun-Feng
    Fang, Zhong-Ze
    Zhang, Yan-Yan
    Hu, Cui-Min
    Sun, Xiao-Yu
    Yu, Zhen-Wen
    Zhu, Xu
    Hong, Mo
    Yang, Lu
    Sun, Hong-Zhi
    PHYTOTHERAPY RESEARCH, 2013, 27 (09) : 1358 - 1361
  • [34] INTERACTION OF CYTOCHROME P450 3A4 AND UDP-GLUCURONOSYLTRANSFERASE 2B7: POSSIBLE INVOLVEMENT OF A REGION LOCATED IN THE J-HELIX OF CYP3A4 IN THE INTERACTION
    Ishii, Yuji
    Takeda, Shuso
    Nurrochmad, Arief
    Iwamoto, Yuki
    Ito, Yuji
    Mackenzie, Peter I.
    Nagata, Kiyoshi
    Yamazoe, Yasushi
    Oguri, Kazuta
    Yamada, Hideyuki
    DRUG METABOLISM REVIEWS, 2007, 39 : 301 - 302
  • [35] Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes
    Roymans, D
    Van Looveren, C
    Leone, A
    Parker, JB
    McMillian, M
    Johnson, MD
    Koganti, A
    Gilissen, R
    Silber, P
    Mannens, G
    Meuldermans, W
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (03) : 427 - 437
  • [36] Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6
    Munzel, PA
    Bookjans, G
    Mehner, G
    Lehmkoster, T
    Bock, KW
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 335 (01) : 205 - 210
  • [37] Functional co-expression of xenobiotic metabolizing enzymes, rat cytochrome P450 1A1 and UDP-glucuronosyltransferase 1A6, in yeast microsomes
    Ikushiro, S
    Sahara, M
    Emi, Y
    Yabusaki, Y
    Iyanagi, T
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2004, 1672 (02): : 86 - 92
  • [38] THE REGULATION OF THE CARCINOGEN DETOXIFYING UDP-GLUCURONOSYLTRANSFERASE UGT1A7 BY 2,3,7,8-TETRACHLORDIBENZO-P-DIOXIN (TCDD) IS ALTERED BY A FUNCTIONAL PROMOTER VARIANT
    Ehmer, U.
    Kalthoff, S.
    Erichsen, T. J.
    Freiberg, N.
    Manns, M. P.
    Strassburg, C. P.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S261 - S261
  • [39] Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates
    Bettonte, Sara
    Berton, Mattia
    Stader, Felix
    Battegay, Manuel
    Marzolini, Catia
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (04) : 353 - 362
  • [40] Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates
    Sara Bettonte
    Mattia Berton
    Felix Stader
    Manuel Battegay
    Catia Marzolini
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 353 - 362